|Articles|September 21, 2022
Operational Impact of Annex 1 Update (Sept 2022)
Author(s)Veltek Associates, Inc.
The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
4
Rare Disease Treatments: Navigating the Economics of Global Innovation
5